|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?
|
5R01CA127617-05
|
$616,079
|
Mandelblatt, Jeanne
|
GEORGETOWN UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-12
|
$1,428,925
|
PIWNICA-WORMS, DAVID
|
WASHINGTON UNIVERSITY
|
|
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
|
5R01CA095045-10
|
$276,360
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Vitamin D and Prostate Cancer: Biomarkers and Genetic Variation
|
5R01CA138639-03
|
$280,070
|
NEUHOUSER, MARIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Vitamin D Analogs for Chemoprevention of Prostate CAncer
|
5R01CA095367-08
|
$374,697
|
FOSTER, BARBARA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
2R01CA044722-22A1
|
$202,321
|
Studzinski, George
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses
|
5R21CA149869-02
|
$159,319
|
McFadden, Grant
|
UNIVERSITY OF FLORIDA
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Vindoline and Vinblastine
|
5R01CA115526-07
|
$327,298
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
Videoconference CBT for Rural Breast Cancer Survivors with Cognitive Complaints
|
5R21CA143619-02
|
$143,613
|
Ferguson, Robert
|
EASTERN MAINE MEDICAL CENTER
|
|
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
|
5R01CA155311-02
|
$322,642
|
Schneider, Bryan
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers
|
5R01CA129226-05
|
$450,265
|
STEIN, MICHAEL
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-05
|
$1,070,400
|
Gore, John
|
VANDERBILT UNIVERSITY MED CTR
|
|
Validation of prognostic and pathway signatures in lethal prostate cancer
|
5U01CA157703-02
|
$525,083
|
FEBBO, PHILLIP
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-02
|
$316,438
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-04
|
$352,231
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-03
|
$296,440
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
1P01CA154291-01A1
|
$1,651,535
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIABC010975
|
$233,465
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIABC010661
|
$272,375
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
5R01CA125691-05
|
$350,125
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
|
5R21CA161182-02
|
$153,590
|
Spitz, Douglas
|
UNIVERSITY OF IOWA
|
|
Using FAP to Selectively Target Epithelial Cancers
|
1R01CA163930-01A1
|
$372,632
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Using EMP2 for Image Guided Drug Delivery for Breast Cancer
|
1R01CA163971-01A1
|
$319,550
|
Wadehra, Madhuri
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIABC005673
|
$641,141
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
5R01CA102792-10
|
$330,925
|
Boothman, David
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Use of 2-deoxy-D-glucose & PI3K/Akt pathway inhibitors in head & neck cancer ther
|
5K01CA134941-04
|
$113,750
|
Burnett, Andrean
|
UNIVERSITY OF IOWA
|
|
USE AND OUTCOMES OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
|
1R03CA167454-01
|
$77,500
|
Tsai, Huei-Ting
|
GEORGETOWN UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas SPORE in Lung Cancer
|
5P50CA070907-15
|
$2,300,000
|
MINNA, JOHN
|
UNIV OF TX SW MED CTR-DALLAS
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-10
|
$2,300,000
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-28
|
$2,138,730
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|